Previous Close | 45.90 |
Open | 46.22 |
Bid | 46.33 x 1400 |
Ask | 46.41 x 1000 |
Day's Range | 46.07 - 46.76 |
52 Week Range | 28.74 - 55.03 |
Volume | 68,997 |
Avg. Volume | 93,108 |
Net Assets | 287.46M |
NAV | 45.86 |
PE Ratio (TTM) | N/A |
Yield | 0.26% |
YTD Daily Total Return | -2.28% |
Beta (5Y Monthly) | 0.00 |
Expense Ratio (net) | 0.47% |
Inception Date | 2019-06-11 |
Biotech companies use or modify biological processes in order to create new pharmaceuticals or therapies. The biotech sector is particularly closely followed right now as a number of biotech companies around the world rush to develop potential vaccines for COVID-19.
Yahoo Finance's Seana Smith and ETF Trends CIO and Director Dave Nadig discuss the outlook on biotech ETFs as optimism grows over results for coronavirus treatments.